Roche signals cutbacks

Friday 3 September 2010

The Roche Group has launched a review of its staffing levels and other expenses in light of pressure on revenue from healthcare reform in the US and Europe and set-backs in its late-stage drug pipeline. Details will be announced before the end of 2010.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Switzerland